GB-3015

N/A

Report date: 2022/10/18 14:46:04

Base Information

Drug NameGB-3015
Drug Alias NameGB-3015
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > TCR therapy
Mechanisms of ActionT lymphocyte replacementsEpstein-Barr virus inhibitors
TargetsEpstein-Barr virus
Therapy Area/IndicationsNasopharyngeal CarcinomaEpstein-Barr Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Genechem Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Genechem Co Ltd
Inactive CompaniesN/A
Active IndicationsNasopharyngeal CarcinomaEpstein-Barr Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A